Double-blind, placebo-controlled homeopathic pathogenetic trials: Symptom collection and analysis

Homeopathy

Volumn 95, Issue 3, 2006, Pages 123-130

  Dominici, G ^a   Bellavite, P ^b   di Stanislao, C ^c   Gulia, P ^d   Pitari, G ^e  

^a Centro Omeopatico Vescovio   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Centro Prev Malattie Respiratorie   (Italy)

^d Istituto di Ricerca Medico   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

homeopathic proving; pathogenetic trial; placebo; standardized methodology; symptoms classification

Indexed keywords

HOMEOPATHIC AGENT; HYDROGEN PEROXIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EVALUATION; FEMALE; HOMEOPATHIC PATHOGENETIC TRIAL; HOMEOPATHY; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; NORMAL HUMAN; NULL HYPOTHESIS; OUTCOME ASSESSMENT; RATING SCALE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VOLCANO;

DOUBLE-BLIND METHOD; HOMEOPATHY; HUMANS; MATERIA MEDICA; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33745382008     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2006.04.003     Document Type: Article

References (27)

1. Herrick N. Animal Mind, Human Voices: Provings of Eight New Animal Remedies (1998), PA Hahnemann Clinic Publishing, Nevada City, CA
2. Evans M. Meditative Provings (2000), The Rose Press, York
3. Brunnthaler-Tscherten R. Calcarea muriatica-remedy proving and experience in practice. Proceedings of 58th Congress LMHI, Graz, April 22-26, 2003.
4. Brien S., Lewith G., and Bryant T. Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C. Br J Clin Pharmacol 56 5 (2003) 562-568
5. Walach H., Koster H., Hennig T., and Haag G. The effects of homeopathic belladonna 30CH in healthy volunteers. A randomized, double-blind experiment. J. Psychosom Res 50 (2001) 155-160
6. Walach H., Sherr J., Schneider R., Shabi R., Bond A., and Rieberer G. Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study. Homeopathy 93 4 (2004) 179-185
7. Brien S. Attitudes about complementary and alternative medicine did not predict outcome in a homeopathic proving trial. J Altern Complement Med 10 3 (2004) 503-505
8. Vickers A., McCarney R., Fisher P., and van Haselen R. Can homeopaths detect homeopathic medicines? A pilot study for a randomised, double-blind, placebo controlled investigation of the proving hypothesis. Br Homeopath J 90 3 (2001) 126-130
9. Gulia P, Pitari G, Dominici G. Etna lava. Sperimentazione omeopatica della lava del vulcano Etna. Il medico omeopata. Giornale FIAMO (www.fiamo.it), VII,21, 26-35.
10. Wieland F. Good homeopathic provings. The need for GHP guidelines. A brief survey of recent developments in methodology of homeopathc drug provings in Europe. Br Homeopath J 86 (1997) 229-234
11. International Council for Classical Homoeopathy. Recommendation guidelines for good provings, International Council for Classical Homoeopathy. Hom Links 12 1 (1999) 29-33
12. Fayeton S., and van Wassenhoven M. Clinical verification of symptom pictures of homoeopathic medicines. Br Homeopath J 90 (2001) 29-32
13. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5 11 (2004) 863-873
14. Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567 1 (2004) 1-61
15. Watt B.E., Proudfoot A.T., and Vale J.A. Hydrogen peroxide poisoning. Toxicol Rev 23 1 (2004) 51-57
16. Kamsler A., and Segal M. Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29 2 (2004) 167-178
17. Kent J.T. Repertory of Homeopathic Materia Medica (1990), B. Jain Publisher, Pvt Ltd, New Delhi
18. Schrojens F. Radar Synthesis 8.1. Archibel, Assesse, Belgium (www.archibel.com).
19. Goodyear K., Lewith G., and Low J.L. Randomized double-blind placebo-controlled trial of homoeopathic 'proving' for Belladonna C30. J R Soc Med 91 11 (1998) 579-582
20. Vickers A.J., van Haselen R., and Heger M. Can homeopathically prepared mercury cause symptoms in healthy volunteers? A randomized, double-blind placebo-controlled trial. J Altern Complement Med 7 2 (2001) 141-148
21. Signorini A., Lubrano A., Manuele G., et al. Classical and new proving methodology: Provings of Plumbum metallicum and Piper methysticum and comparison with a classical proving of Plumbum metallicum. Homeopathy 94 3 (2005) 164-174
22. Mollinger H., Schneider R., Loffel M., and Walach H. A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: comparing two high potencies. Forsch Komplementarmed Klass Nat 11 5 (2004) 274-280
23. Jonas W.B., Anderson R.L., Crawford C.C., and Lyons J.S. A systematic review of the quality of homeopathic clinical trials. BMC complement. Altern Med 1 1 (2001) 12
24. Linde K., Clausius N., Ramirez G., et al. Are the clinical effects of homeopathy placebo effects? A meta analysis of placebo-controlled trials. Lancet 350 9081 (1997) 834-843
25. Linde K., Scholz M., Ramirez G., Clausius N., Melchart D., and Jonas W.B. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 52 7 (1999) 631-636
26. Hyland M.E., and Lewith G.T. Oscillatory effects in a homeopathic clinical trial. Homeopathy 91 (2002) 145-149
27. Bellavite P. Complexity science and homeopathy: a synthetic overview. Homeopathy 92 (2003) 203-212